Torticollis
RecruitingStudy on IPN10200 for Treating Cervical Dystonia in Adults
Study on IPN10200 for Treating Cervical Dystonia in Adults
- Disease:Torticollis
- Substances:–
Italy- Participants:18–64 years · 65+ years
- Sponsor:Ipsen Innovation
Rare diseases
Investigational molecules
Locations
Back to Italy2 907 clinical trials in Legnano, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on IPN10200 for Treating Cervical Dystonia in Adults
ItalyStudy on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyStudy of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease
Italy
ItalyStudy on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease
ItalyStudy on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure
ItalyStudy of Nadofaragene Firadenovec for Adults with Intermediate Risk Non-Muscle Invasive Bladder Cancer
ItalyStudy on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments
ItalyStudy on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis
ItalyStudy on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
ItalyStudy comparing rilvegostomig plus chemotherapy versus pembrolizumab plus chemotherapy for first-line treatment in patients with metastatic non-squamous lung cancer with PD-L1 expression
ItalyThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Myeloma treatments, including innovative therapies for relapsed and refractory cases. Studies evaluating new drug combinations and treatment approaches for better patient outcomes.
Multiple ongoing trials testing various therapeutic combinations to improve survival rates.
Groundbreaking studies in lung cancer and breast cancer treatment, investigating novel immunotherapy combinations and targeted therapies.
Focus on personalized treatment approaches and biomarker-driven therapies.
Innovative research in chronic kidney disease and HIV management, exploring new treatment strategies and medication combinations.
Studies aimed at improving long-term patient outcomes and quality of life.
Tell us about your condition – we search every trial in Europe and connect you with the right site.